These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33858231)

  • 1. Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination.
    Bisgin A; Sanlioglu AD; Eksi YE; Griffith TS; Sanlioglu S
    Hum Gene Ther; 2021 Jun; 32(11-12):541-562. PubMed ID: 33858231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2020 race towards SARS-CoV-2 specific vaccines.
    Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
    Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the design and development of SARS-CoV-2 vaccines.
    Peng XL; Cheng JS; Gong HL; Yuan MD; Zhao XH; Li Z; Wei DX
    Mil Med Res; 2021 Dec; 8(1):67. PubMed ID: 34911569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.
    Tostanoski LH; Wegmann F; Martinot AJ; Loos C; McMahan K; Mercado NB; Yu J; Chan CN; Bondoc S; Starke CE; Nekorchuk M; Busman-Sahay K; Piedra-Mora C; Wrijil LM; Ducat S; Custers J; Atyeo C; Fischinger S; Burke JS; Feldman J; Hauser BM; Caradonna TM; Bondzie EA; Dagotto G; Gebre MS; Jacob-Dolan C; Lin Z; Mahrokhian SH; Nampanya F; Nityanandam R; Pessaint L; Porto M; Ali V; Benetiene D; Tevi K; Andersen H; Lewis MG; Schmidt AG; Lauffenburger DA; Alter G; Estes JD; Schuitemaker H; Zahn R; Barouch DH
    Nat Med; 2020 Nov; 26(11):1694-1700. PubMed ID: 32884153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic.
    Liu CH; Huang HY; Tu YF; Lai WY; Wang CL; Sun JR; Chien Y; Lin TW; Lin YY; Chien CS; Huang CH; Chen YM; Huang PI; Wang FD; Yang YP
    J Chin Med Assoc; 2021 Jan; 84(1):9-13. PubMed ID: 33186212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: Coronavirus Vaccine Development Updates.
    Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
    Front Immunol; 2020; 11():602256. PubMed ID: 33424848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
    Liu R; Americo JL; Cotter CA; Earl PL; Erez N; Peng C; Moss B
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33688035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus disease-19 vaccine development utilizing promising technology.
    Wang Y; Xing M; Zhou D
    Curr Opin HIV AIDS; 2020 Nov; 15(6):351-358. PubMed ID: 32969973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Challenges of Vaccine Development Against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector].
    Zaichuk TA; Nechipurenko YD; Adzhubey AA; Onikienko SB; Chereshnev VA; Zainutdinov SS; Kochneva GV; Netesov SV; Matveeva OV
    Mol Biol (Mosk); 2020; 54(6):922-938. PubMed ID: 33276356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases.
    Xu Z; Ho M; Bordoloi D; Kudchodkar S; Khoshnejad M; Giron L; Zaidi F; Jeong M; Roberts CC; Park YK; Maslow J; Abdel-Mohsen M; Muthumani K
    Methods Mol Biol; 2022; 2410():229-263. PubMed ID: 34914050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.
    Sharma O; Sultan AA; Ding H; Triggle CR
    Front Immunol; 2020; 11():585354. PubMed ID: 33163000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
    Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential approaches to combat COVID-19: a mini-review.
    Sarwar Z; Ahmad T; Kakar S
    Mol Biol Rep; 2020 Dec; 47(12):9939-9949. PubMed ID: 33185828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
    Russell RL; Pelka P; Mark BL
    Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena.
    Chavda VP; Bezbaruah R; Athalye M; Parikh PK; Chhipa AS; Patel S; Apostolopoulos V
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.